B-CELL NON HODGKIN LYMPHOMA
Clinical trials for B-CELL NON HODGKIN LYMPHOMA explained in plain language.
Never miss a new study
Get alerted when new B-CELL NON HODGKIN LYMPHOMA trials appear
Sign up with your email to follow new studies for B-CELL NON HODGKIN LYMPHOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Can a rheumatoid arthritis drug tame CAR-T's worst side effects?
Disease control CompletedThis study tested whether anakinra, a drug used for rheumatoid arthritis, could prevent two serious side effects of CAR-T therapy: cytokine release syndrome (CRS) and nerve damage. 27 adults with B-cell lymphoma received anakinra alongside their CAR-T treatment. The goal was to s…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE2 • Sponsor: Fred Hutchinson Cancer Center • Aim: Disease control
Last updated May 26, 2026 04:18 UTC
-
New combo therapy boosts survival in kids with aggressive blood cancers
Disease control CompletedThis study tested whether adding 6 doses of the drug rituximab to standard chemotherapy helps children and teens with advanced B-cell lymphoma or leukemia live longer without the cancer coming back. About 482 high-risk patients aged 6 months to 18 years took part. The goal was to…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE3 • Sponsor: Gustave Roussy, Cancer Campus, Grand Paris • Aim: Disease control
Last updated May 26, 2026 04:17 UTC
-
Engineered immune cells take aim at Hard-to-Treat blood cancers
Disease control CompletedThis study tested whether a new type of immune cell therapy, called CD22 CAR T cells, could be made from the blood of adults with certain blood cancers (leukemia and lymphoma) that had come back or not responded to treatment. The main goals were to see if the cells could be succe…
Matched conditions: B-CELL NON HODGKIN LYMPHOMA
Phase: PHASE1 • Sponsor: Matthew Frank • Aim: Disease control
Last updated May 18, 2026 12:07 UTC